| related words |
| corlux |
| therapeutic |
| orphan |
| therapy |
| exclusivity |
| nexavar |
| commercialized |
| novel |
| gene |
| stent |
| recothrom |
| feraheme |
| bidil |
| soliris |
| labeling |
| tarceva |
| hematide |
| protein |
| investigational |
| genetic |
|
| related documents |
| 1059784--10/10/2008--GENEREX_BIOTECHNOLOGY_CORP |
| 310158--2/29/2008--SCHERING_PLOUGH_CORP |
| 1059784--10/15/2007--GENEREX_BIOTECHNOLOGY_CORP |
| 1059784--10/16/2006--GENEREX_BIOTECHNOLOGY_CORP |
| 1444570--12/17/2010--Axcan_Intermediate_Holdings_Inc. |
| 1178104--9/24/2010--CARDICA_INC |
| 716646--6/14/2010--CLINICAL_DATA_INC |
| 874663--5/21/2010--ALKERMES_INC |
| 881524--3/10/2010--VIVUS_INC |
| 844856--3/31/2010--VAPOR_CORP. |
| 1230355--3/12/2010--TRANS1_INC |
| 1183765--3/8/2010--THRESHOLD_PHARMACEUTICALS_INC |
| 1172480--3/4/2010--SANTARUS_INC |
| 1390478--3/31/2010--RXI_PHARMACEUTICALS_CORP |
| 1041024--3/12/2010--ROCKWELL_MEDICAL_TECHNOLOGIES_INC |
| 1285819--3/31/2010--OMEROS_CORP |
| 1235010--3/12/2010--MOMENTA_PHARMACEUTICALS_INC |
| 64978--3/30/2010--MERCK_SHARP_&_DOHME_CORP. |
| 1158895--3/29/2010--LEMAITRE_VASCULAR_INC |
| 1087432--3/15/2010--INTERMUNE_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {property, intellectual, protect} |
| {product, market, service} |
| {customer, product, revenue} |
| {acquisition, growth, future} |
| {control, financial, internal} |
| {loss, insurance, financial} |
| {operation, international, foreign} |
| {gas, price, oil} |
| {condition, economic, financial} |
| {debt, indebtedness, cash} |
| {operation, natural, condition} |
| {loan, real, estate} |
| {provision, law, control} |
| {financial, litigation, operation} |
| {regulation, government, change} |
| {system, service, information} |
| {stock, price, operating} |
| {cost, operation, labor} |
|